Faculty profile

James Johnston

ResearcherSchool of Population and Public HealthUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.

James Johnston

Researcher

School of Population and Public Health

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
18 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 4 research grants (4 CIHR), most recently in 2025.
Supervisor on 1 trainee award (1 CIHR), most recently in 2019.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Tuberculosis Lung Health Public Health Genomic Epidemiology Genomics Outbreak Risk Transmission

Latest papers

Population Pharmacokinetic Modeling of Standard- and High-Dose Rifampicin for Tuberculosis Preventive Therapy in the 2R2 Randomized Controlled Trial.
The Journal of infectious diseases · 2026
Drug-Resistant Tuberculous Meningitis (DR-TBM) in a Low-Incidence Setting: Two Cases and an Evidence Review Highlighting Key Advances and Knowledge Gaps in Clinical Management.
Open forum infectious diseases · 2026
A scoping review of interventions to prevent and treat adverse events during treatment of rifampin-susceptible tuberculosis.
PloS one · 2025

All 32 publications

Latest funding

Community-Engaged Co-Production of Tuberculosis Screening and Prevention Strategies for Marginalised Urban Communities
CIHR · 2025 · Nominated PI
$125,000
Looking past 'cure': refining our understanding of the long-term impacts of tuberculosis
CIHR · 2019 · Supervisor
$105,000
A Precision Public Health Approach to Eliminating Tuberculosis Transmission: Using Linked Genomic and Administrative Data to Prevent Outbreaks
CIHR · 2018 · Principal investigator
$180,000

All 7 grants and awards

32 publications.

Population Pharmacokinetic Modeling of Standard- and High-Dose Rifampicin for Tuberculosis Preventive Therapy in the 2R2 Randomized Controlled Trial.

Gafar F, Svensson EM, Yunivita V, Fregonese F, Fisher D, Fox GJ, Nguyen TA, Nguyen BH, Johnston J, Long R, Valiquette C, Aarnoutse RE, Ruslami R, Menzies D

The Journal of infectious diseases2026

DOI: 10.1093/infdis/jiag052 PMID: 41589392

Drug-Resistant Tuberculous Meningitis (DR-TBM) in a Low-Incidence Setting: Two Cases and an Evidence Review Highlighting Key Advances and Knowledge Gaps in Clinical Management.

Boschung KF, Wong PHP, Werry D, Sekirov I, Turvey SL, Cook VJ, Johnston J, Connors WJA

Open forum infectious diseases2026

DOI: 10.1093/ofid/ofag046 PMID: 41756205

A scoping review of interventions to prevent and treat adverse events during treatment of rifampin-susceptible tuberculosis.

Burman WJ, Martins MF, Flynn D, Johnston J, Sinha P, Horsburgh CR

PloS one2025

DOI: 10.1371/journal.pone.0339354 PMID: 41452912

Moral distress among health care workers and decision-makers undermines tuberculosis infection screening and treatment programs for migrants in Canada: a reflexive thematic analysis.

Law S, Armstrong G, Schwartzman K, Campbell JR, Johnston J, Silva DS

BMC health services research2025

DOI: 10.1186/s12913-025-13822-2 PMID: 41361742

Treatment of Drug-Resistant Tuberculosis with Bedaquiline, Pretomanid, Linezolid with or Without Moxifloxacin (BPaL/M): Feasibility and Implementation Challenges in Western Canada.

Muir P, Cook VJ, Sekirov I, Johnston J, Connors WJ

Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada2025

DOI: 10.3138/jammi-2024-0034 PMID: 40673052

Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin Treatment for Multi-Drug Resistant Extrapulmonary Tuberculosis in Canada: A Report.

Fung JS, Cook VJ, Johnston J, Connors WJ

Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada2025

DOI: 10.3138/jammi-2024-0025 PMID: 40673047

Representativeness and adverse event reporting in late-phase clinical trials for rifampin-susceptible tuberculosis: a systematic review.

Burman W, Luczynski P, Horsburgh CR, Phillips PPJ, Johnston J

The Lancet. Infectious diseases2025Senior author

DOI: 10.1016/s1473-3099(24)00597-8 PMID: 39612926

Role of IPF genetic risk loci in post-COVID-19 lung abnormalities: a cohort study.

Marinescu DC, Wong AW, Shah A, Hague CJ, Murphy D, Yang J, Johnston J, Leung J, Carlsten C, Ryerson CJ

BMJ open respiratory research2025

DOI: 10.1136/bmjresp-2024-002725 PMID: 39832890

Predictable excess hepatotoxicity in the SimpliciTB trial.

Burman W, Horsburgh CR, Johnston J

The Lancet. Infectious diseases2024Senior author

DOI: 10.1016/s1473-3099(24)00598-x PMID: 39481423

Research on the treatment of rifampin-susceptible tuberculosis-Time for a new approach.

Burman W, Rucsineanu O, Horsburgh CR, Johnston J, Dorman SE, Menzies D

PLoS medicine2024

DOI: 10.1371/journal.pmed.1004438 PMID: 39052666

Something wrong or missing on this profile? Suggest a correction

James Johnston

Research

Latest papers

Latest funding

Population Pharmacokinetic Modeling of Standard- and High-Dose Rifampicin for Tuberculosis Preventive Therapy in the 2R2 Randomized Controlled Trial.

Drug-Resistant Tuberculous Meningitis (DR-TBM) in a Low-Incidence Setting: Two Cases and an Evidence Review Highlighting Key Advances and Knowledge Gaps in Clinical Management.

A scoping review of interventions to prevent and treat adverse events during treatment of rifampin-susceptible tuberculosis.

Moral distress among health care workers and decision-makers undermines tuberculosis infection screening and treatment programs for migrants in Canada: a reflexive thematic analysis.

Treatment of Drug-Resistant Tuberculosis with Bedaquiline, Pretomanid, Linezolid with or Without Moxifloxacin (BPaL/M): Feasibility and Implementation Challenges in Western Canada.

Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin Treatment for Multi-Drug Resistant Extrapulmonary Tuberculosis in Canada: A Report.

Representativeness and adverse event reporting in late-phase clinical trials for rifampin-susceptible tuberculosis: a systematic review.

Role of IPF genetic risk loci in post-COVID-19 lung abnormalities: a cohort study.

Predictable excess hepatotoxicity in the SimpliciTB trial.

Research on the treatment of rifampin-susceptible tuberculosis-Time for a new approach.

Community-Engaged Co-Production of Tuberculosis Screening and Prevention Strategies for Marginalised Urban Communities

Looking past 'cure': refining our understanding of the long-term impacts of tuberculosis

A Precision Public Health Approach to Eliminating Tuberculosis Transmission: Using Linked Genomic and Administrative Data to Prevent Outbreaks

From Patient to Policy: Using data to drive TB elimination in Canada's foreign born population

Evidence to action for Canadian and global mobile health (mHealth) communication to promote patient engagement in care: a rigorous implementation science approach

Applying syndemic/core group theory to improve integrated prevention and service delivery for HIV and related epidemics

Improving health system efficiency in latent tuberculosis treatment through text messaging.

Frequent collaborators

Richard Long

Victoria Cook

Andrea Benedetti

Andrea Benedetti

Kevin Schwartzman

Patrick Tang

Inna Sekirov

Stephanie Law

Rovina Ruslami

Luis Nacul

Kamila Romanowski

Janice Leung

Lehana Thabane

Lehana Thabane

Jason Wong

Erin Strumpf

Christopher Carlsten

Mohsen Sadatsafavi